{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013048","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.508776+00:00","generated_at":"2026-05-17T06:53:03.581198+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PAVmed subsidiary Lucid Diagnostics closes $28.75M stock offering at $1.00/share","bullets":["Lucid Diagnostics sold 28.75M shares at $1.00 each via underwritten offering.","Underwriters' option for 3.75M shares exercised in full at closing.","Net proceeds expected to be approximately $26.9 million after expenses.","Funds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013048","json":"https://secwatch.observer/filing/0001493152-25-013048.json","markdown":"https://secwatch.observer/filing/0001493152-25-013048.md","text":"https://secwatch.observer/filing/0001493152-25-013048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225013048/0001493152-25-013048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315225013048/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:53:03.581198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}